Thus, concomitant administration of GSI and glutaminase (GLS) inhibitors showed synergistic anti-leukemic effects against Pten-positive T-ALLs, while Pten-negative leukemias were resistant not only to GSI but also to the combination of both GSI and GLS inhibitors. Here, GLS is linked to leukemia.